Tag: FDA

Study: Spatial and racial disparities in COVID-19 mortality rates

Editor's Note This study from the University of Chicago finds an association between social determinants of health measures and COVID-19 mortality rates that varied across racial and ethnic groups and community types. Among 3,142 counties in the study, 531 were identified as concentrated longitudinal-impact counties. Of these, 347 (11%) had…

Read More

By: Judy Mathias
March 7, 2022
Share

ANSI/AAMI publishes long-waited ST91 updates

Editor's Note After 7 years, ANSI/AAMI has updated its standard for cleaning and storing medical devices, such as flexible bronchoscopes and various endoscopes. The updated standard, “ANSI/AAMI ST91:2021, Flexible and semi-rigid endoscope processing in health care facilities,” addresses new technologies and concerns about device cleanliness and patient safety. “ANSI/AAMI ST91:2021…

Read More

By: Judy Mathias
March 3, 2022
Share

FDA: Class I recall of Arrow International’s Arrow-Trerotola PTD

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of Vyaire Medical’s Bellavista Ventilators

Editor's Note The Food and Drug Administration (FDA) on February 17 identified the recall by Vyaire Medical (Mettawa, Illinois) of its Bellavista 1000 and 1000e Series Ventilators as Class I, the most serious. The recall was initiated because of issues with the software version 6.0.1600.0 or higher, after reports of…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of BASE10 Genetics RNAstill MTM specimen collection kits

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by BASE10 Genetics of its RNAstill MTM specimen collection kits as Class I, the most serious. The specimen collection kits are intended for collection, transport, inactivation, stabilization, and long-term storage of nasopharyngeal or oropharyngeal swab samples…

Read More

By: Judy Mathias
February 23, 2022
Share

FDA: Class I recall of E25Bio COVID-19 Direct Antigen Rapid Tests

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by E25Bio (Cambridge, Massachusetts) of its COVID-19 Direct Antigen Rapid Tests as Class I, the most serious. The tests are being recalled for several reasons, particularly because they were marketed and distributed in the US without…

Read More

By: Judy Mathias
February 22, 2022
Share

HHS says more funding is needed to combat COVID-19

Editor's Note According to the February 16 Becker’s Hospital Review, Health and Human Services (HHS) Secretary Xiaver Becerra said the Biden administration is estimating it will need some $30 billion to continue to fight against COVID-19. Another HHS representative told Politico the funding is needed "for additional resources to support…

Read More

By: Tarsilla Moura
February 17, 2022
Share

Effectiveness of reprocessing ureteroscopes, other endoscopic devices

Each year, there are more studies raising concerns about infections associated with endoscopic procedures and the techniques used to clean and sterilize or high-level disinfect (HLD) endoscopic devices. In this article, in partnership with Boston Scientific, epidemiologist Cori L. Ofstead, MSPH, president and CEO of Ofstead & Associates, St Paul,…

Read More

By: Judith M. Mathias, MA, RN
February 16, 2022
Share

HHS to give $66.5 million towards community-based outreach to boost COVID-19 vaccination rates

Editor's Note According to the February 10 Healthcare Purchasing News, the US Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a new American Rescue Plan funding of $66.5 million to help expand outreach efforts to boost COVID-19 vaccine rates. The funding will…

Read More

By: Tarsilla Moura
February 10, 2022
Share

FDA: Class I recall of Empowered Diagnostics COVID-19 tests

Editor's Note The Food and Drug Administration (FDA) on January 28 identified the recall by Empowered Diagnostics (Pompano Beach, Florida) of its CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test as Class I, the most serious. Empowered Diagnostics distributed these tests with labeling indicating they were…

Read More

By: Judy Mathias
February 8, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat